Skip to main content
. 2003 Nov;71(11):6435–6445. doi: 10.1128/IAI.71.11.6435-6445.2003

FIG. 2.

FIG. 2.

Inhibition of FMLP-mediated chemotaxis by N-t-BOC. A total of 5 × 105 purified human neutrophils was placed in the upper well of a chemotaxis chamber with various concentrations of N-t-BOC (0 to 800 μM) and an antagonist of the high-affinity FPR. FMLP (50 nM) was placed in the lower chamber. Greater than 95% inhibition of FMLP-mediated chemotaxis occurred with the use of concentrations of N-t-BOC that were greater than 400 μM.